¿Puede ser el rituximab una opción terapéutica de primera línea en pacientes con nefropatía membranosa idiopática grave?
Read
13497
Timeswas read the article
3503
Total PDF
9994
Total HTML
Article information
ISSN: 18889700Original language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 81 | 7 | 88 |
| 2025 5 | 225 | 48 | 273 |
| 2025 4 | 165 | 25 | 190 |
| 2025 3 | 162 | 64 | 226 |
| 2025 2 | 135 | 37 | 172 |
| 2025 1 | 105 | 38 | 143 |
| 2024 12 | 115 | 32 | 147 |
| 2024 11 | 109 | 73 | 182 |
| 2024 10 | 115 | 49 | 164 |
| 2024 9 | 76 | 37 | 113 |
| 2024 8 | 104 | 91 | 195 |
| 2024 7 | 101 | 53 | 154 |
| 2024 6 | 104 | 47 | 151 |
| 2024 5 | 99 | 43 | 142 |
| 2024 4 | 87 | 45 | 132 |
| 2024 3 | 76 | 24 | 100 |
| 2024 2 | 85 | 39 | 124 |
| 2024 1 | 86 | 35 | 121 |
| 2023 12 | 86 | 25 | 111 |
| 2023 11 | 86 | 21 | 107 |
| 2023 10 | 117 | 26 | 143 |
| 2023 9 | 128 | 47 | 175 |
| 2023 8 | 119 | 39 | 158 |
| 2023 7 | 118 | 42 | 160 |
| 2023 6 | 152 | 24 | 176 |
| 2023 5 | 125 | 30 | 155 |
| 2023 4 | 87 | 19 | 106 |
| 2023 3 | 85 | 28 | 113 |
| 2023 2 | 84 | 28 | 112 |
| 2023 1 | 80 | 25 | 105 |
| 2022 12 | 97 | 37 | 134 |
| 2022 11 | 121 | 35 | 156 |
| 2022 10 | 87 | 39 | 126 |
| 2022 9 | 66 | 38 | 104 |
| 2022 8 | 85 | 49 | 134 |
| 2022 7 | 83 | 49 | 132 |
| 2022 6 | 67 | 52 | 119 |
| 2022 5 | 89 | 52 | 141 |
| 2022 4 | 94 | 58 | 152 |
| 2022 3 | 133 | 90 | 223 |
| 2022 2 | 110 | 55 | 165 |
| 2022 1 | 121 | 39 | 160 |
| 2021 12 | 83 | 75 | 158 |
| 2021 11 | 150 | 73 | 223 |
| 2021 10 | 152 | 78 | 230 |
| 2021 9 | 132 | 77 | 209 |
| 2021 8 | 149 | 43 | 192 |
| 2021 7 | 105 | 59 | 164 |
| 2021 6 | 108 | 46 | 154 |
| 2021 5 | 146 | 49 | 195 |
| 2021 4 | 271 | 69 | 340 |
| 2021 3 | 143 | 51 | 194 |
| 2021 2 | 111 | 65 | 176 |
| 2021 1 | 103 | 28 | 131 |
| 2020 12 | 98 | 31 | 129 |
| 2020 11 | 100 | 21 | 121 |
| 2020 10 | 98 | 38 | 136 |
| 2020 9 | 93 | 11 | 104 |
| 2020 8 | 98 | 29 | 127 |
| 2020 7 | 88 | 43 | 131 |
| 2020 6 | 76 | 33 | 109 |
| 2020 5 | 104 | 28 | 132 |
| 2020 4 | 50 | 24 | 74 |
| 2020 3 | 78 | 29 | 107 |
| 2020 2 | 113 | 24 | 137 |
| 2020 1 | 116 | 33 | 149 |
| 2019 12 | 110 | 39 | 149 |
| 2019 11 | 90 | 39 | 129 |
| 2019 10 | 93 | 32 | 125 |
| 2019 9 | 90 | 40 | 130 |
| 2019 8 | 78 | 26 | 104 |
| 2019 7 | 110 | 39 | 149 |
| 2019 6 | 75 | 24 | 99 |
| 2019 5 | 149 | 38 | 187 |
| 2019 4 | 147 | 57 | 204 |
| 2019 3 | 60 | 23 | 83 |
| 2019 2 | 43 | 30 | 73 |
| 2019 1 | 37 | 24 | 61 |
| 2018 12 | 83 | 42 | 125 |
| 2018 11 | 98 | 16 | 114 |
| 2018 10 | 58 | 14 | 72 |
| 2018 9 | 59 | 16 | 75 |
| 2018 8 | 63 | 26 | 89 |
| 2018 7 | 79 | 19 | 98 |
| 2018 6 | 101 | 25 | 126 |
| 2018 5 | 85 | 16 | 101 |
| 2018 4 | 227 | 23 | 250 |
| 2018 3 | 135 | 18 | 153 |
| 2018 2 | 85 | 9 | 94 |
| 2018 1 | 85 | 11 | 96 |
| 2017 12 | 91 | 12 | 103 |
| 2017 11 | 77 | 6 | 83 |
| 2017 10 | 71 | 13 | 84 |
| 2017 9 | 109 | 11 | 120 |
| 2017 8 | 133 | 15 | 148 |
| 2017 7 | 58 | 9 | 67 |
Show all
